Animal farming and the risk of lymphohaematopoietic cancers: a meta-analysis of three cohort studies within the AGRICOH consortium.


Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
11 2019
Historique:
received: 18 12 2018
revised: 10 06 2019
accepted: 22 06 2019
pubmed: 16 7 2019
medline: 17 3 2020
entrez: 15 7 2019
Statut: ppublish

Résumé

Animal farming entails a variety of potential exposures, including infectious agents, endotoxins and pesticides, which may play a role in the aetiology of lymphohaematopoietic cancers (LHCs). The aim of this study was to assess whether farming specific animal species is associated with the risk of overall LHC or its subtypes. Data from three prospective cohort studies in the USA, France and Norway which are part of the Agricultural Cohort consortium and which collected information about animal farming and cancer were used. Analyses included 316 270 farmers and farm workers. Adjusted Cox models were used to investigate the associations of 13 histological subtypes of LHC (n=3282) with self-reported livestock (cattle, pigs and sheep/goats) and poultry (ever/never and numbers raised) farming. Cohort-specific HRs were combined using random-effects meta-analysis. Ever animal farming in general or farming specific animal species was not meta-associated with overall LHC. The risk of myeloid malignancies decreased with increasing number of livestock (p trend=0.01). Increased risk of myeloproliferative neoplasms was seen with increasing number of sheep/goats (p trend <0.01), while a decreased risk was seen with increasing number of livestock (p trend=0.02). Between cohorts, we observed heterogeneity in the association of type of animal farmed and various LHC subtypes. This large-scale study of three prospective agricultural cohorts showed no association between animal farming and LHC risk, but few associations between specific animal species and LHC subtypes were observed. The observed differences in associations by countries warrant further investigations.

Identifiants

pubmed: 31302607
pii: oemed-2018-105655
doi: 10.1136/oemed-2018-105655
pmc: PMC10304413
mid: NIHMS1907042
doi:

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

827-837

Subventions

Organisme : Intramural NIH HHS
ID : Z01 CP010119
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA CP010119
Pays : United States
Organisme : NCI NIH HHS
ID : Z01 CP010119
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Am J Hematol. 1991 Oct;38(2):147-9
pubmed: 1951308
Cancer Causes Control. 2002 Aug;13(6):563-71
pubmed: 12195646
J Occup Environ Med. 2010 Nov;52(11):1098-105
pubmed: 21063187
Leuk Res. 2004 Jul;28(7):713-24
pubmed: 15158093
Occup Environ Med. 2009 May;66(5):291-8
pubmed: 19017688
Int Arch Occup Environ Health. 2015 Jan;88(1):61-73
pubmed: 24599726
Ann Occup Hyg. 2009 Aug;53(6):595-603
pubmed: 19561032
Occup Environ Med. 2016 Jun;73(6):359-67
pubmed: 27009271
Environ Health Perspect. 2016 Apr;124(4):396-405
pubmed: 26340796
Lancet Oncol. 2015 Aug;16(8):891-2
pubmed: 26111929
Int J Epidemiol. 2019 Oct 1;48(5):1519-1535
pubmed: 30880337
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Occup Environ Med. 2005 Oct;62(10):726-35
pubmed: 16169919
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Cancer. 1996 May 15;77(10):2157-61
pubmed: 8640685
PLoS One. 2014 Oct 22;9(10):e109332
pubmed: 25337994
Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2382-7
pubmed: 18768507
J Environ Monit. 2006 Jan;8(1):63-72
pubmed: 16395461
Am J Epidemiol. 2011 Jan 1;173(1):71-83
pubmed: 21084556
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44
pubmed: 25174034
Br J Cancer. 1986 Sep;54(3):493-500
pubmed: 3756085
Vet Res. 1994;25(6):521-36
pubmed: 7889034
J Natl Cancer Inst. 1984 Jun;72(6):1233-40
pubmed: 6587145
Int J Environ Res Public Health. 2011 May;8(5):1341-57
pubmed: 21655123
Int J Hyg Environ Health. 2015 Oct;218(7):577-89
pubmed: 26272513
Occup Environ Med. 2003 Aug;60(8):e3
pubmed: 12883030
Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1903-12
pubmed: 24962839
Chest. 2009 Sep;136(3):716-725
pubmed: 19318669
Blood. 2007 Jul 15;110(2):695-708
pubmed: 17389762
Scand J Work Environ Health. 1996 Feb;22(1):14-26
pubmed: 8685669
Thorax. 2012 Dec;67(12):1112; author reply 1112-3
pubmed: 22234726
Br J Ind Med. 1992 Feb;49(2):95-103
pubmed: 1536825
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):369-72
pubmed: 17372232
Am J Ind Med. 2002 Aug;Suppl 2:54-61
pubmed: 12210683
Q Rev Biol. 2008 Dec;83(4):339-62
pubmed: 19143335
Environ Health Perspect. 2009 Sep;117(9):1344-50
pubmed: 19750096
J Environ Sci (China). 2018 May;67:23-35
pubmed: 29778157
Cancer Causes Control. 2012 May;23(5):663-70
pubmed: 22407136
J Occup Environ Med. 2010 Jan;52(1):39-53
pubmed: 20042883
J Expo Anal Environ Epidemiol. 2002 Nov;12(6):418-26
pubmed: 12415490
Scand J Work Environ Health. 2004 Jun;30(3):215-22
pubmed: 15250650
Int J Cancer. 2013 Jun 1;132(11):2613-8
pubmed: 23065666
Environ Health Perspect. 1996 Apr;104(4):362-9
pubmed: 8732939
Front Public Health. 2014 Feb 13;2:14
pubmed: 24592380

Auteurs

Sonia El-Zaemey (S)

School of Public Health, Curtin University, Perth, Western Australia, Australia.
Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.

Leah H Schinasi (LH)

Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
Departmentof Environmental and Occupational Health, School of Public Health, Drexel University, Philadelphia, USA.

Gilles Ferro (G)

Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.

Séverine Tual (S)

ANTICIPE, U1086 INSERM, Université de Caen Normandie, and Centre deLutte Contre le Cancer François Baclesse, Caen, France.

Pierre Lebailly (P)

ANTICIPE, U1086 INSERM, Université de Caen Normandie, and Centre deLutte Contre le Cancer François Baclesse, Caen, France.

Isabelle Baldi (I)

CHU de Bordeaux, Service de Médecine du Travail et PathologieProfessionnelle, Bordeaux, France.

Karl-Christian Nordby (KC)

Department of Occupational Medicine and Epidemiology, National Institute of Occupational Health (STAMI), Oslo, Norway.

Kristina Kjærheim (K)

Department of Research, Cancer Registry of Norway, Oslo, Norway.

Joachim Schüz (J)

Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.

Alain Monnereau (A)

Hematological Malignancies Registry of Gironde, Bergonie Institute, Comprehensive Cancer Centre, Bordeaux, France.
University of Bordeaux, INSERM U1219 Center - EPICENE Team, CHU de Bordeaux, Bordeaux, France.

Maartje Brouwer (M)

Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands.

Stella Koutros (S)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, USA.

Jonathan Hofmann (J)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, USA.

Petter Kristensen (P)

Department of Occupational Medicine and Epidemiology, National Institute of Occupational Health (STAMI), Oslo, Norway.

Hans Kromhout (H)

Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands.

Maria E Leon (ME)

Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.

Laura E Beane Freeman (LE)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH